Original research
par
Dadiomov, David et al
Date de publication
2022
Géographie
USA
Langue de la ressource
English
Texte disponible en version intégrale
Non
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
During the COVID-19 pandemic, federal agencies relaxed buprenorphine prescribing restrictions including for incarcerated individuals. The impact of COVID-19 on the supply of MOUD in U.S. prisons and jails is not known.
Constatations/points à retenir
In prisons and jails, MOUD supply increased rapidly in early 2020 and then continued to increase during the COVID-19 pandemic.MOUD growth in prisons and jails was exclusively due to increases in buprenorphine/naloxone.
La conception ou méthodologie de recherche
We used cross-sectional national monthly data.
Mots clés
Policy/Regulatory
Legal system/law enforcement
Substitution/OAT
